Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

NeuroPhage
222 Third Street, Suite 3120
Cambridge, MA 2142
Phone: 617-714-5468
www.neurophage.com

NeuroPhage is a biotechnology company focusing on a unique approach for treating diseases involving protein aggregation. NeuroPhage was founded in 2007 by a Cambridge-based team along with Professor Beka Solomon, Chair for Biotechnology of Neurodegenerative Diseases at Tel Aviv University.

Key Contact
Name
Jonathan Solomon, MBA
Title
President and CEO
Funding Events

Date
Amount
Type
Investors
Valuation
03/08/12 $9,000,000 Series B-1
05/06/13 $6,400,000 Merieux Developpement
Shire Strategic Investment Group
undisclosed
01/14/15 $10,000,000 Series D Extension